Technical Analysis for AMRN - Amarin Corporation plc

Grade Last Price % Change Price Change
grade F 4.78 -7.72% -0.40
AMRN closed down 7.72 percent on Friday, April 3, 2020, on 2.01 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical AMRN trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
180 Bearish Setup Bearish Swing Setup -7.72%
Volume Surge Other -7.72%
Calm After Storm Range Contraction -7.72%
Narrow Range Bar Range Contraction -7.72%
Lower Bollinger Band Walk Weakness -7.72%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.
Biopharmaceutical Organic Compounds Nutrition Cardiovascular Diseases Cholesterol Lipids Low Density Lipoprotein Hypertriglyceridemia Saturated Fat

Is AMRN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.12
52 Week Low 3.95
Average Volume 13,001,251
200-Day Moving Average 17.55
50-Day Moving Average 14.83
20-Day Moving Average 10.62
10-Day Moving Average 9.43
Average True Range 1.74
ADX 33.17
+DI 19.28
-DI 46.79
Chandelier Exit (Long, 3 ATRs ) 11.02
Chandelier Exit (Short, 3 ATRs ) 9.17
Upper Bollinger Band 16.98
Lower Bollinger Band 4.25
Percent B (%b) 0.04
BandWidth 119.88
MACD Line -2.47
MACD Signal Line -1.87
MACD Histogram -0.6038
Fundamentals Value
Market Cap 1.29 Billion
Num Shares 271 Million
EPS -0.31
Price-to-Earnings (P/E) Ratio -15.42
Price-to-Sales 5.87
Price-to-Book 0.00
PEG Ratio -1.74
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.80
Resistance 3 (R3) 5.85 5.57 5.63
Resistance 2 (R2) 5.57 5.31 5.54 5.57
Resistance 1 (R1) 5.17 5.15 5.03 5.12 5.52
Pivot Point 4.89 4.89 4.82 4.86 4.89
Support 1 (S1) 4.49 4.63 4.35 4.44 4.04
Support 2 (S2) 4.21 4.47 4.18 3.99
Support 3 (S3) 3.81 4.21 3.93
Support 4 (S4) 3.76